HOME >> MEDICINE >> NEWS
Enzyme replacement therapy found to effectively treat patients with Fabry disease

confirms the long-term safety and effectiveness of enzyme replacement therapy for patients with Fabry," said Dr. Wilcox.

Named Fabry disease after the dermatologist who first noted the symptoms back in the 19th century, it was only recently discovered that the disease is an inherited disorder caused by the lack of a particular enzyme called a-galactosidase A or a-GAL. The enzyme is needed to break down a fatty substance in cells called globotriaosylceramide or GL-3. But when a-GAL is lacking, GL-3 builds up in blood vessel walls and does increasing damage to organs such as the heart, kidney and brain. By the time that the disease is diagnosed, the organs have often sustained damage, ultimately leading to an early death.

"Raul's bout with the disease is similar to many other patients with Fabry, as even now, the disease is often undiagnosed until adulthood when organs have started being affected," said Dr. Wilcox. "Now we have a drug that replaces the deficient enzyme so that patients can live longer and better."

In the study, Raul was one of 58 patients selected at random to receive r-haGAL or a placebo by infusion every two weeks for a 20-week period. After completing 20 weeks of the study, all 58 patients have been receiving an infusion of r-haGAL every two-weeks for over 18 months. Patients' response to the drug was monitored via kidney and heart function tests. Tissue biopsies were also performed to assess organ function and a specialized questionnaire was used to assess patient pain levels. The investigators found that pain was significantly improved overall, while pathology studies confirmed that GL-3, or the fatty substance in cells, was consistently reduced throughout the study period. Kidney function remained stable throughout treatment during the 18-month period indicating that the disease was not causing further damage.

Although the investigators found that the majority of patients began producing antibodies i
'"/>

Contact: Kelli Stauning
kelli.stauning@cshs.org
310-423-3674
Cedars-Sinai Medical Center
24-Oct-2002


Page: 1 2 3

Related medicine news :

1. Enzyme linked to mania and schizophrenia impairs higher brain functions
2. Enzyme prevents lung damage in premature infants
3. Enzyme found in blood vessels likely target to treat lung injury
4. Enzyme structure holds key to cocaine, heroin metabolism
5. Enzyme level linked to death after angioplasty
6. Enzyme halts muscle waste in mouse models of most-common childhood muscular dystrophy
7. Enzyme could provide continual fat burning
8. Growing your own replacement teeth? Not science fiction!
9. Premature infants with lung disease may continue to need replacement substance to ease breathing
10. Biotech breakthrough in islet cell replacement for type 1 diabetes
11. MDCT is better than plain film in diagnosing hip replacement complications

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2019)... , ... December 06, 2019 , ... ... recognized for its innovations and excellence in patient care. On December 12th, Hartford ... of excellence at the Health Care Heroes Awards at the Hartford Marriott. , ...
(Date:12/6/2019)... , ... December 06, 2019 , ... Allegheny Health Network ... Dr. Gyure, who joined AHN from WVU Medicine in May 2018, previously served as ... has served as interim chair since October and is also part of the pathology ...
(Date:12/6/2019)... ... December 06, 2019 , ... COMPLIANCY GROUP is proud ... Wyoming Medical Society. Compliancy Group is dedicated to educating and assisting Wyoming Medical ... adhere to the standards set forth by the Health Insurance Portability and Accountability ...
(Date:12/6/2019)... ... ... TIME For Kids (TFK) revealed the first-ever list of the World’s ... that are tailored to the interests of kids. The list identifies The Children’s Museum ... TIME for Kids gathered nominations from its network of TFK Kid Reporters ...
(Date:12/5/2019)... ... December 05, 2019 , ... A cohort ... (HRUS) technology to help their patients more easily detect ruptured silicone gel implants. ... this study and reporting on his experience. While the FDA currently recommends regular ...
Breaking Medicine News(10 mins):
(Date:12/9/2019)... , ... December 09, 2019 , ... ... most people contend with are not ‘sebaceous,’” notes Dr. Robert Levine, a dual-board-certified ... epidermoid – also called ‘epidermal’ – cysts, which have their own distinct structure.” ...
(Date:12/8/2019)... (PRWEB) , ... December 07, 2019 , ... ... years to have over 700 weekly ongoing face-to-face mutual support groups in 32 ... nicotine addiction. , Nicotine Anonymous members also provide several daily phone and internet ...
(Date:12/6/2019)... ... December 06, 2019 , ... In order to help pharmacies ... introducing the CSEDOIC luminaire series. CSEDOIC fixtures are designed for healthcare cleanrooms, where ... hazardous drugs (HDs) and HD-active pharmaceutical ingredients from the original container be done ...
Breaking Medicine Technology:
Cached News: